Expertise in
2
conditions

Dr. Deborah Burke

Neurology
Office
5 Tampa General Cir Ste 410, 
Tampa, FL 
Expertise in
2
conditions
Office
5 Tampa General Cir Ste 410, 
Tampa, FL 

Overview

Deborah Burke is a Neurologist in Tampa, Florida. Dr. Burke is highly rated in 2 conditions, according to our data. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Cerebellar Degeneration.

Her clinical research consists of participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Neurology

Licenses

Psychiatry & Neurology in FL

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Office
5 Tampa General Cir Ste 410, Tampa, FL 33606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease
Enrollment Status: Completed
Publish Date: October 08, 2024
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
Enrollment Status: Withdrawn
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: February 13, 2024
Intervention Type: Drug
Study Drug: SPN-812
Study Phase: Phase 3
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Enrollment Status: Completed
Publish Date: July 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost
A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost
Enrollment Status: Completed
Publish Date: July 11, 2022
Intervention Type: Drug
Study Drug: Oral Fasudil
Study Phase: Phase 2
View 8 Less Clinical Trials
Similar Doctors
Expertise in
14
conditions
Dr. Robert Hauser
Neurology
Expertise in
14
conditions
Dr. Robert Hauser
Neurology

USF Health Parkinsons Disease & Movement Disorders

4001 E Fletcher Ave Fl 6, 
Tampa, FL 
 (10.1 miles away)
813-396-0751
Experience:
44+ years
Languages Spoken:
English
See accepted insurances

Robert Hauser is a Neurologist in Tampa, Florida. Dr. Hauser has been practicing medicine for over 44 years is highly rated in 14 conditions, according to our data. His top areas of expertise are Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, and Tardive Dyskinesia.

Expertise in
13
conditions
Dr. Selim Benbadis
Neurology
Expertise in
13
conditions
Dr. Selim Benbadis
Neurology

Office

2 Tampa General Cir Ste 730, 
Tampa, FL 
 (1.5 miles away)
813-821-8034
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Selim Benbadis is a Neurologist in Tampa, Florida. Dr. Benbadis is highly rated in 13 conditions, according to our data. His top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Absence Seizure, and Gastrostomy.

Expertise in
14
conditions
Dr. Maxim Mokin
Neurology
Expertise in
14
conditions
Dr. Maxim Mokin
Neurology

Univ. Medical Service Association Inc.

2 Tampa General Cir, 
Tampa, FL 
 (0.1 miles away)
813-259-0965
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maxim Mokin is a Neurologist in Tampa, Florida. Dr. Mokin is highly rated in 14 conditions, according to our data. His top areas of expertise are Stroke, Brain Aneurysm, Apoplexy, Thrombectomy, and Stent Placement.

Frequently Asked Questions about Dr. Deborah Burke

How do I make an appointment with Dr. Deborah Burke?

You can book an appointment with Dr. Deborah Burke by calling their office at 813-866-1600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Deborah Burke a top-rated expert for Parkinson's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Deborah Burke is classified as an Distinguished expert for Parkinson's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Deborah Burke specialize in?

While Dr. Deborah Burke is a Neurology, they have specific expertise in Parkinson's Disease, Movement Disorders, and Lewy Body Dementia (LBD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Deborah Burke accept my insurance?

Dr. Deborah Burke accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 813-866-1600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Burke's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile